The Board of Directors of The Medicines Company appointed Dr. Sarah Schlesinger as a new, independent Director of the company, effective immediately. Dr. Schlesinger has spent more than twenty years working in the field of cellular immunity. She is currently the Chair of The Rockefeller University Hospital’s Institutional Review Board and Senior Physician and Associate Professor of Clinical Investigation at The Rockefeller University.